Axikin Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.axikin.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
- First Posted Date
- 2013-07-01
- Last Posted Date
- 2016-02-05
- Lead Sponsor
- Axikin Pharmaceuticals, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT01890161
- Locations
- 🇨🇦
Vancouver General Hospital, The Lung Centre, Vancouver, British Columbia, Canada
🇨🇦McMaster University, Hamilton, Ontario, Canada
🇨🇦IUCPQ, Institut de cardiologie et de pneumologie de l'Hôpital Laval, Quebec, Canada
News
No news found